Molecular pathogenesis of bladder cancer

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Bladder tumors exhibit diverse histopathology and clinical behaviors, correlating with distinct molecular genetic profiles.
• Extensive data exists on somatic genomic alterations in bladder tumors across various grades and stages.
• These genetic alterations, when mapped to histopathological features, have informed a two-pathway model for bladder tumor pathogenesis.

Purpose of the Study:

• To review and synthesize reported genetic alterations in bladder cancer.
• To relate these genetic findings to the established two-pathway model of tumor development.
• To explore the unclear molecular pathogenesis of high-grade noninvasive papillary and T1 bladder tumors.

Main Methods:

• Literature review of published studies on genetic alterations in bladder cancer.
• Correlation of genetic findings with histopathological classifications.
• Discussion of existing models and identification of knowledge gaps.

Main Results:

• A two-pathway model for bladder tumor pathogenesis has emerged based on accumulated genetic and histopathological data.
• Specific genetic alterations are associated with distinct tumor types and behaviors.
• The molecular basis for high-grade noninvasive papillary and T1 tumors remains incompletely understood.

Conclusions:

• The current two-pathway model provides a framework for understanding bladder cancer development.
• Understanding genetic alterations is crucial for classifying and potentially treating bladder tumors.
• Further investigation into the molecular pathogenesis of specific bladder tumor subtypes is warranted.